Academic Journal
Towards ending the perioperative metformin controversy : a narrative review
| Τίτλος: | Towards ending the perioperative metformin controversy : a narrative review |
|---|---|
| Συγγραφείς: | Van Hove, K., Coremans, P., Van Oers, F., de Block, C. |
| Πηγή: | 0001-5164 ; Acta anaesthesiologica belgica |
| Έτος έκδοσης: | 2026 |
| Συλλογή: | IRUA - Institutional Repository van de Universiteit Antwerpen |
| Θεματικοί όροι: | Human medicine |
| Περιγραφή: | Metformin is the most widely prescribed oral glucose-lowering medication and serves as the first-line treatment for type 2 diabetes mellitus due to its efficacy, cost-effectiveness, and favourable safety profile. Given its widespread use, perioperative management of metformin is a common clinical challenge. Concerns regarding metformin and lactic acidosis have historically led to recommendations for its preoperative discontinuation. Recent studies, including randomized controlled trials, have found no significant difference in lactic acidosis risk between patients who continue or discontinue metformin perioperatively. However, these studies are highly heterogeneous, and the randomized controlled trials include a limited number of patients; on the other hand, metformin-induced and metformin-associated lactic acidosis are uncommon. We conducted an extensive narrative review of perioperative metformin guidelines, including ten publications from 2015 to 2024. Seven out of ten guidelines support continuing metformin in patients without risk factors, such as impaired renal function or the use of contrast agents. When risk factors are present, most guidelines recommend withholding metformin on the morning of surgery. There has been a notable shift in recommendations regarding resumption. Guidelines published before 2020 advised waiting 48 hours postoperatively, but more recent guidance suggests metformin can be restarted once adequate oral intake is established and renal function is confirmed to be stable. However, definitive large-scale randomized trials are still needed to establish standardized recommendations. |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/isi/001721922400007 |
| DOI: | 10.56126/77.1.06 |
| Διαθεσιμότητα: | https://doi.org/10.56126/77.1.06 https://hdl.handle.net/10067/2219010151162165141 https://repository.uantwerpen.be/docstore/d:irua:34487 |
| Rights: | info:eu-repo/semantics/openAccess |
| Αριθμός Καταχώρησης: | edsbas.AF4D7F0F |
| Βάση Δεδομένων: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://doi.org/10.56126/77.1.06# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.AF4D7F0F RelevancyScore: 1011 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1010.63568115234 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Towards ending the perioperative metformin controversy : a narrative review – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Van+Hove%2C+K%2E%22">Van Hove, K.</searchLink><br /><searchLink fieldCode="AR" term="%22Coremans%2C+P%2E%22">Coremans, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Van+Oers%2C+F%2E%22">Van Oers, F.</searchLink><br /><searchLink fieldCode="AR" term="%22de+Block%2C+C%2E%22">de Block, C.</searchLink> – Name: TitleSource Label: Source Group: Src Data: 0001-5164 ; Acta anaesthesiologica belgica – Name: DatePubCY Label: Publication Year Group: Date Data: 2026 – Name: Subset Label: Collection Group: HoldingsInfo Data: IRUA - Institutional Repository van de Universiteit Antwerpen – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Human+medicine%22">Human medicine</searchLink> – Name: Abstract Label: Description Group: Ab Data: Metformin is the most widely prescribed oral glucose-lowering medication and serves as the first-line treatment for type 2 diabetes mellitus due to its efficacy, cost-effectiveness, and favourable safety profile. Given its widespread use, perioperative management of metformin is a common clinical challenge. Concerns regarding metformin and lactic acidosis have historically led to recommendations for its preoperative discontinuation. Recent studies, including randomized controlled trials, have found no significant difference in lactic acidosis risk between patients who continue or discontinue metformin perioperatively. However, these studies are highly heterogeneous, and the randomized controlled trials include a limited number of patients; on the other hand, metformin-induced and metformin-associated lactic acidosis are uncommon. We conducted an extensive narrative review of perioperative metformin guidelines, including ten publications from 2015 to 2024. Seven out of ten guidelines support continuing metformin in patients without risk factors, such as impaired renal function or the use of contrast agents. When risk factors are present, most guidelines recommend withholding metformin on the morning of surgery. There has been a notable shift in recommendations regarding resumption. Guidelines published before 2020 advised waiting 48 hours postoperatively, but more recent guidance suggests metformin can be restarted once adequate oral intake is established and renal function is confirmed to be stable. However, definitive large-scale randomized trials are still needed to establish standardized recommendations. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Language Label: Language Group: Lang Data: English – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: info:eu-repo/semantics/altIdentifier/isi/001721922400007 – Name: DOI Label: DOI Group: ID Data: 10.56126/77.1.06 – Name: URL Label: Availability Group: URL Data: https://doi.org/10.56126/77.1.06<br />https://hdl.handle.net/10067/2219010151162165141<br />https://repository.uantwerpen.be/docstore/d:irua:34487 – Name: Copyright Label: Rights Group: Cpyrght Data: info:eu-repo/semantics/openAccess – Name: AN Label: Accession Number Group: ID Data: edsbas.AF4D7F0F |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.AF4D7F0F |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.56126/77.1.06 Languages: – Text: English Subjects: – SubjectFull: Human medicine Type: general Titles: – TitleFull: Towards ending the perioperative metformin controversy : a narrative review Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Van Hove, K. – PersonEntity: Name: NameFull: Coremans, P. – PersonEntity: Name: NameFull: Van Oers, F. – PersonEntity: Name: NameFull: de Block, C. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2026 Identifiers: – Type: issn-locals Value: edsbas – Type: issn-locals Value: edsbas.oa Titles: – TitleFull: 0001-5164 ; Acta anaesthesiologica belgica Type: main |
| ResultId | 1 |